| Price | 2,051.00p on 24-04-2026 at 11:03:47 |
|---|---|
| Change | -25.00p -1.2% |
| Buy | 2,052.00p |
| Sell | 2,050.00p |
| Last Trade: | Unknown 220.00 at 2,051.00p |
| Day's Volume: | 951,963 |
| Last Close: | 2,076.00p |
| Open: | 2,070.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 2,047.00p - 2,071.00p |
| 52wk Range: | 1,315.00p - 2,282.00p |
| Market Capitalisation: | £81.87b |
| VWAP: | 2,053.77635p |
| Shares in Issue: | 3.99b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 220 | 2,051.00p | SI Trade |
12:03:47 - 24-Apr-26 |
| Sell* | 1,020 | 2,051.00p | Automatic Execution |
12:03:27 - 24-Apr-26 |
| Buy* | 116 | 2,051.00p | Automatic Execution |
12:03:16 - 24-Apr-26 |
| Buy* | 195 | 2,051.00p | Automatic Execution |
12:03:16 - 24-Apr-26 |
| Buy* | 287 | 2,051.00p | Automatic Execution |
12:03:16 - 24-Apr-26 |
| Buy* | 3,386 | 2,051.00p | Automatic Execution |
12:03:16 - 24-Apr-26 |
| Buy* | 29 | 2,051.00p | Automatic Execution |
12:03:16 - 24-Apr-26 |
| Buy* | 152 | 2,051.00p | Automatic Execution |
12:03:16 - 24-Apr-26 |
| Buy* | 22 | 2,051.00p | Automatic Execution |
12:03:16 - 24-Apr-26 |
| Buy* | 174 | 2,051.00p | Automatic Execution |
12:03:16 - 24-Apr-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 23rd Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 22nd Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 21st Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 20th Apr 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 20th Apr 2026 7:00 am | RNS | Blenrep approved in China for 2L+ multiple myeloma |
| 20th Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 17th Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 16th Apr 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 16th Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 15th Apr 2026 7:12 am | RNS | GSK completes acquisition of 35Pharma Inc. |